EGFR and glioblastoma: In this study, they reported that EGFRvIII CART secreting EGFR BiTE not only targeted EGFRvIII+positive GBM cells, but also wild type EGFR positive cells were targeted by untransduced bystander endogenous T cells through BiTE.